Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Analyst Ratings For Roku

Analysts have provided the following ratings for Roku (NASDAQ:ROKU) within the last quarter:

Benzinga

Analyzing Walgreens Boots Alliance Inc's Short Interest

Walgreens Boots Alliance Inc's (NASDAQ:WBA) short percent of float has fallen 14.69% since its last report. The company recently reported that it has 17.45 million shares sold short, which is 2.44% of all regular shares that are available for trading.

Benzinga

What 4 Analyst Ratings Have To Say About IAC/InterActive

Analysts have provided the following ratings for IAC/InterActive (NASDAQ:IAC) within the last quarter:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Analyst Ratings For Match Group

Within the last quarter, Match Group (NASDAQ:MTCH) has observed the following analyst ratings:

Benzinga

WillScot Mobile Mini Acquires Storstac For Undisclosed Sum

Willscot Mobile Mini Holdings Corp (NASDAQ:WSC) closed the acquisition of Canadian storage services provider Storstac Inc. Deal terms were not disclosed. This acquisition adds over 1,100 storage units to WSC's existing markets in the greater Toronto area. The company funded the transaction with cash on hand and borrowings under its revolving credit agreement.…

Benzinga

Insurance Stocks Moving In Monday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga

BZ Chart of the Day: QQQ Gaps Lower

It looks like the selloff in the technology sector will continue. The Invesco QQQ Trust ETF (NASDAQ: QQQ) is gapping lower. The bears seem to be firmly in control.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

5 Cannabis Stocks Wall Street Analysts Rate Buy: No, Tilray Is Not Among Them

The cannabis industry blossomed during the pandemic, some say unexpect

Benzinga

Was WWE's WrestleMania 38 Bigger Than Super Bowl LVI? Here's What Social Media Data Says

When it comes to social media popularity, the spectacle of Brock Lesnar and Roman Reigns pummeling each other was more popular than the matchup between the Los Angeles Rams and the Cincinnati Bengals.

Benzinga

Cellectis Reveals Preclinical Data On First Allogeneic Dual CAR T-Cell Product In Non-Hodgkin Lymphoma

Cellectis SA (NASDAQ:CLLS) released preclinical data on its product candidate UCART20x22 at the American Association for Cancer Research (AACR) Annual Meeting. The Company said that the data showed preclinical proof of concept with the potential to overcome common mechanisms of resistance to CAR T-cell therapies in relapsed or refractory Non-Hodgkin Lymphoma (r/r NHL),…

Benzinga

Merger Arbitrage Mondays - WindAcre Doubles Its Stake In Nielsen Holdings (NLSN) And Other Deals

Merger activity decreased last week with three new deals announced and six deals completed. Tivity Health (NASDAQ: TVTY)

Benzinga

If You Invested $1,000 In Microsoft Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

Where GoodRx Holdings Stands With Analysts

Over the past 3 months, 13 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

What Are Whales Doing With Amazon.com

Someone with a lot of money to spend has taken a bearish stance on Amazon.com (NASDAQ:AMZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 3 Analyst Ratings Have To Say About JetBlue Airways

Over the past 3 months, 3 analysts have published their opinion on JetBlue Airways (NASDAQ:JBLU) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Michael Grimm Purchases $5.66 Million Worth Of Energy Transfer & Other Notable Insider Buys

Natural gas prices were range bound for the better part of the last decade, oscillating between $2 and $4 per million British thermal units (MMBtu) with the occasional spike outside that tight range.

Benzinga

Where T. Rowe Price Gr Stands With Analysts

T. Rowe Price Gr (NASDAQ:TROW) has observed the following analyst ratings within the last quarter:

Benzinga

Matinas BioPharma Inks mRNA-Based Vaccine Pact With BioNTech

BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Does Elon Musk's About-Face On Twitter Portend 'Game Of Thrones' Battle Ahead?

Tesla, Inc. (NASDAQ: TSLA) CEO Elon Musk disclosure of a passive stake in Twitter, Inc.

Benzinga

Here's Why Iveda Solutions Shares Are Rising

Iveda Solutions Inc (NASDAQ: IVDA) shares are trading higher by 41.7% at $3.09 after the company announced the launch of Utilus.

Benzinga

Trinity Biotech Stock Surges After $45M Capital Infusion From Korea-Based Firm

Trinity Biotech plc (NASDAQ: TRIB) announced a

Benzinga

How Amazon, Disney And Others Are Beating Netflix At Its Own Game: Analyst

Streaming giant Netflix, Inc. (NASDAQ: NFLX) is slowly and steadily ceding its dominant market positioning, according to a survey by KeyBanc Capital Markets.

Benzinga

$1000 Invested In CSX 20 Years Ago Would Be Worth This Much

CSX (NASDAQ:CSX) has outperformed the market over the past 20 years by 8.1% on an annualized basis producing an average annual return of 15.18%. Currently, CSX has a market capitalization of $74.75 billion.

Benzinga

Cancer Drug Maker BeiGene Takes Action to Mitigate Delisting Risk

Key Takeaways: BeiGene has switched auditors for its New York listing to a U.S. company from a Chinese one in a move to comply with U.S. law The change could reduce the company’s threat of being forcibly delisted from the Nasdaq By Doug Young

Benzinga

MNOV: Genzyme Patent Litigation Could Lead to Significant Payout…

By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT

1 … 708 709 710 711

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.